Clinical Trial Update: Influence of CYP3A5 Polymorphism on Liver Function Abnormality and the Trough Level Change After Conversion [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining whether CYP3A5 genetic variation influences liver function abnormalities and trough drug level changes after a conversio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Dysfunction

Snippet

Sponsor: Seoul National University Hospital | Conditions: Liver Dysfunction | Phase 4 | Status: UNKNOWN